EIF4EBP1 and hepatocellular carcinoma: EIF4EBP1 contributes to carcinogenesis in lung adenocarcinoma, hepatocellular carcinoma, and nasopharyngeal carcinoma, and its suppression inhibits ccRCC cell proliferation, migration, and invasion [64–67].